{"entity":{"type":"insider","cik":"0001808509","url":"/insider/0001808509","json_url":"/insider/0001808509.json","name":"Shetzline Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":11,"first":"2021-03-02","last":"2026-02-25","span_basis":"filed_date"},"name_variants":[{"name":"Shetzline Michael","source":"filing","n_filings":11,"first_seen":"2021-03-02","last_seen":"2026-02-25"}],"transactions":[{"id":6058467,"accession":"0001193125-26-071503","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-071503","line_url":"/filing/0001193125-26-071503#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (SVP, CMO, Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (SVP, CMO, Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CMO, Head-Res&Drug","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17012.0,"shares_display":"17,012","price_per_share":3.66,"price_display":"3.66","price_state":"stated","total_value":62263.92,"total_display":"62,263.92","total_whole":"62,264","shares_owned_after":521425.0,"shares_owned_after_display":"521,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-25","scope":"insider"},{"id":6058465,"accession":"0001193125-26-071503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-071503","line_url":"/filing/0001193125-26-071503#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (SVP, CMO, Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (SVP, CMO, Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CMO, Head-Res&Drug","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15570.0,"shares_display":"15,570","price_per_share":3.81,"price_display":"3.81","price_state":"stated","total_value":59321.7,"total_display":"59,321.70","total_whole":"59,322","shares_owned_after":538437.0,"shares_owned_after_display":"538,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":5156676,"accession":"0000950170-25-019235","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-019235","line_url":"/filing/0000950170-25-019235#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (SVP, CMO, Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (SVP, CMO, Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CMO, Head-Res&Drug","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41269.0,"shares_display":"41,269","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":72633.44,"total_display":"72,633.44","total_whole":"72,633","shares_owned_after":554007.0,"shares_owned_after_display":"554,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":2304403,"accession":"0000950170-24-063481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-063481","line_url":"/filing/0000950170-24-063481#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (CMO,SVP,Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (CMO,SVP,Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO,SVP,Head-Res&Drug","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16128.0,"shares_display":"16,128","price_per_share":6.45,"price_display":"6.45","price_state":"stated","total_value":104025.6,"total_display":"104,025.60","total_whole":"104,026","shares_owned_after":413719.0,"shares_owned_after_display":"413,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider"},{"id":2824326,"accession":"0000950170-24-015557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-015557","line_url":"/filing/0000950170-24-015557#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (CMO,SVP,Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (CMO,SVP,Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO,SVP,Head-Res&Drug","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38618.0,"shares_display":"38,618","price_per_share":15.24,"price_display":"15.24","price_state":"stated","total_value":588538.32,"total_display":"588,538.32","total_whole":"588,538","shares_owned_after":340484.0,"shares_owned_after_display":"340,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider"},{"id":8629087,"accession":"0001209191-23-031874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-031874","line_url":"/filing/0001209191-23-031874#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (CMO,SVP,Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (CMO,SVP,Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO,SVP,Head-Res&Drug","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10324.0,"shares_display":"10,324","price_per_share":10.12,"price_display":"10.12","price_state":"stated","total_value":104478.88,"total_display":"104,478.88","total_whole":"104,479","shares_owned_after":321131.0,"shares_owned_after_display":"321,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider"},{"id":7949645,"accession":"0001209191-23-014280","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-014280","line_url":"/filing/0001209191-23-014280","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (CMO,SVP,Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (CMO,SVP,Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO,SVP,Head-Res&Drug","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9854.0,"shares_display":"9,854","price_per_share":11.31,"price_display":"11.31","price_state":"stated","total_value":111448.74,"total_display":"111,448.74","total_whole":"111,449","shares_owned_after":264002.0,"shares_owned_after_display":"264,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-01","scope":"insider","n_lines":2},{"id":7949641,"accession":"0001209191-23-014280","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-014280","line_url":"/filing/0001209191-23-014280","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (CMO,SVP,Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (CMO,SVP,Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO,SVP,Head-Res&Drug","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9468.0,"shares_display":"9,468","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":108029.88,"total_display":"108,029.88","total_whole":"108,030","shares_owned_after":273762.0,"shares_owned_after_display":"273,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-01","scope":"insider","n_lines":2},{"id":6985904,"accession":"0001209191-22-031842","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-031842","line_url":"/filing/0001209191-22-031842","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (CMO,SVP,Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (CMO,SVP,Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO,SVP,Head-Res&Drug","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10583.0,"shares_display":"10,583","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":121704.5,"total_display":"121,704.50","total_whole":"121,705","shares_owned_after":266245.0,"shares_owned_after_display":"266,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider","n_lines":2},{"id":6295162,"accession":"0001209191-22-014652","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-014652","line_url":"/filing/0001209191-22-014652","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (CMO,SVP,Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (CMO,SVP,Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO,SVP,Head-Res&Drug","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17607.0,"shares_display":"17,607","price_per_share":10.77,"price_display":"10.77","price_state":"stated","total_value":189627.39,"total_display":"189,627.39","total_whole":"189,627","shares_owned_after":203548.0,"shares_owned_after_display":"203,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider","n_lines":5},{"id":4957824,"accession":"0001209191-21-066780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-066780","line_url":"/filing/0001209191-21-066780#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (CMO,SVP,Head-Res&Drug)","role_mark":"O","role_mark_label":"Officer (CMO,SVP,Head-Res&Drug)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO,SVP,Head-Res&Drug","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13776.0,"shares_display":"13,776","price_per_share":11.58,"price_display":"11.58","price_state":"stated","total_value":159526.08,"total_display":"159,526.08","total_whole":"159,526","shares_owned_after":183661.0,"shares_owned_after_display":"183,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-24","scope":"insider"},{"id":4273790,"accession":"0001209191-21-035905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-035905","line_url":"/filing/0001209191-21-035905#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (CMO, SVP & Head of Drug Devt)","role_mark":"O","role_mark_label":"Officer (CMO, SVP & Head of Drug Devt)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO, SVP & Head of Drug Devt.","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2077.0,"shares_display":"2,077","price_per_share":12.25,"price_display":"12.25","price_state":"stated","total_value":25443.25,"total_display":"25,443.25","total_whole":"25,443","shares_owned_after":197437.0,"shares_owned_after_display":"197,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-26","scope":"insider"},{"id":4983906,"accession":"0001209191-21-016108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-016108","line_url":"/filing/0001209191-21-016108","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001808509","owner_name":"Shetzline Michael","owner_display_name":"Shetzline Michael","owner_url":"/insider/0001808509","role":"Officer (CMO, SVP & Head of Drug Devt)","role_mark":"O","role_mark_label":"Officer (CMO, SVP & Head of Drug Devt)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO, SVP & Head of Drug Devt.","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4439.0,"shares_display":"4,439","price_per_share":9.11,"price_display":"9.11","price_state":"stated","total_value":40439.29,"total_display":"40,439.29","total_whole":"40,439","shares_owned_after":160859.0,"shares_owned_after_display":"160,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-26","filed_date":"2021-03-02","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (SVP, CMO, Head-Res&Drug)","n_filings":11,"first_seen":"2021-03-02","last_seen":"2026-02-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001808509","retrieved_at":"2026-08-24T04:23:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}